EMA's initiative of expanding the use of early background summaries

In an effort to help assessors evaluate initial marketing authorization applications, the European Medicines Agency (EMA) has taken the initiative to extend the use of “early background summaries”.

To read more, click here.


Download PDF Share Back To Listing
Loading data